Search Results - "Bachier, Lizamarie"
-
1
A case series of Monoclonal Gammopathy of Undetermined Significance and COVID‐19
Published in British journal of haematology (01-08-2020)Get full text
Journal Article -
2
Axicabtagene ciloleucel CD19 CAR-T cell therapy results in high rates of systemic and neurologic remissions in ten patients with refractory large B cell lymphoma including two with HIV and viral hepatitis
Published in Journal of hematology and oncology (03-01-2020)“…Axicabtagene ciloleucel (Axi-cel) is a CD-19 Chimeric Antigen Receptor T cell therapy approved for the treatment of relapsed/refractory diffuse large B cell…”
Get full text
Journal Article -
3
Case report of combination therapy with Azacytidine, Enasidenib and Venetoclax in primary refractory AML
Published in Experimental hematology & oncology (04-01-2021)“…Optimal treatment of acute myeloid leukemia (AML) arising in elderly patients remains a challenge. FDA approval of Ivosidenib and Enasidenib, small molecule…”
Get full text
Journal Article -
4
Prophylactic rituximab prevents EBV PTLD in haplo-cord transplant recipients at high risk
Published in Leukemia & lymphoma (07-06-2019)“…Epstein-Barr virus (EBV) reactivation and post-transplant lymphoproliferative disorders (PTLD) are common and potentially fatal complications after allogeneic…”
Get full text
Journal Article -
5
Elevated LDH greater than 400 U/L portends poorer overall survival in diffuse large B-cell lymphoma patients treated with CD19 CAR-T cell therapy in a real world multi-ethnic cohort
Published in Experimental hematology & oncology (09-12-2021)“…Abstract Anti-CD19 chimeric antigen receptor T-cell therapies have shown striking clinical activity in diffuse large B-cell lymphoma but robust biomarkers…”
Get full text
Journal Article -
6
Safety of axicabtagene ciloleucel for relapsed/refractory large B-cell lymphoma in an elderly intercity population
Published in Bone marrow transplantation (Basingstoke) (01-07-2021)Get full text
Journal Article -
7
Intrathecal chemotherapy as treatment for chimeric antigen receptor T cell (CAR T) therapy associated neurotoxicity
Published in Bone marrow transplantation (Basingstoke) (19-09-2024)Get full text
Journal Article -
8
Letermovir prophylaxis lowers the incidence of Non-CMV infections after allogeneic hematopoietic cell transplantation
Published in Bone marrow transplantation (Basingstoke) (01-04-2024)Get full text
Journal Article -
9
-
10
Impact of Acute and Chronic Graft-Versus-Host Disease (GVHD) on Non-Relapse Mortality and Survival Following Haploidentical Donor Transplantation
Published in Transplantation and cellular therapy (01-02-2024)“…The alloimmune response giving rise to the potent graft-versus-malignancy effect of allogeneic transplant can also be associated with morbidity and mortality…”
Get full text
Journal Article -
11
Multiple Myeloma in Hispanics: Incidence, Characteristics, Survival, Results of Discovery, and Validation Using Real-World and Connect MM Registry Data
Published in Clinical lymphoma, myeloma and leukemia (01-04-2021)“…Multiple myeloma (MM) in Hispanics has never been studied. We therefore sought to determine the clinical characteristics and overall survival in MM of…”
Get full text
Journal Article -
12
-
13
-
14
Post-Transplant Maintenance in AML and MDS Patients Undergoing Non-Myeloablative Peripheral Blood Stem Cell Transplant with Post-Transplant Cyclophosphamide
Published in Transplantation and cellular therapy (01-02-2024)“…Disease relapse remains a major cause of mortality for patients with AML and MDS undergoing allogeneic hematopoietic stem cell transplant (HSCT). Several…”
Get full text
Journal Article -
15
HLA-DQ G1/G2 Heterodimer Genotype Impacts Relapse and Survival Following Haploidentical Donor Transplantation Using Post-Transplant Cyclophosphamide
Published in Transplantation and cellular therapy (01-02-2024)“…The importance of the HLA-DR and HLA-DP class II loci following post-transplant cyclophosphamide (PTCy)-based haploidentical donor transplantation (HIDT) has…”
Get full text
Journal Article -
16
-
17
-
18
Seroconversion rates following COVID-19 vaccination among patients with cancer
Published in Cancer cell (09-08-2021)“…As COVID-19 adversely affects patients with cancer, prophylactic strategies are critically needed. Using a validated antibody assay against SARS-CoV-2 spike…”
Get full text
Journal Article -
19
Neurotoxicity of Axicabtagene Ciloleucel and Long-Lerm Outcomes in a Minority Rich, Ethnically Diverse Real World Cohort
Published in Transplantation and cellular therapy (01-03-2022)Get full text
Journal Article -
20
255 - Neurotoxicity of Axicabtagene Ciloleucel and Long-Lerm Outcomes in a Minority Rich, Ethnically Diverse Real World Cohort
Published in Transplantation and cellular therapy (01-03-2022)Get full text
Journal Article